Figures & data
Table 1. The correlation between the lncRNA DARS-AS1 expression level and the Pathological factors of HCC patients
Figure 1. DARS-AS1 expression in HCC tissues and cells and its correlation with HCC prognosis
![Figure 1. DARS-AS1 expression in HCC tissues and cells and its correlation with HCC prognosis](/cms/asset/d4854d02-be69-4588-beec-61ef91388cfb/kbie_a_1982272_f0001_oc.jpg)
Figure 2. DARS-AS1 subserved HCC proliferation, invasion and EMT
![Figure 2. DARS-AS1 subserved HCC proliferation, invasion and EMT](/cms/asset/b87aad4b-0adf-4fcb-a1dd-35552c6ca582/kbie_a_1982272_f0002_oc.jpg)
Figure 3. DARS-AS1 overexpression accelerated the growth and metastasis of HCC cells
![Figure 3. DARS-AS1 overexpression accelerated the growth and metastasis of HCC cells](/cms/asset/4d38274e-3ce0-428a-90d3-f09fc8cfdd56/kbie_a_1982272_f0003_oc.jpg)
Figure 4. DARS-AS1 promoted the CKAP2 expression
![Figure 4. DARS-AS1 promoted the CKAP2 expression](/cms/asset/61f9d398-2365-4af0-9b77-0583202012d2/kbie_a_1982272_f0004_oc.jpg)
Figure 5. Overexpressing CKAP2 heightened the proliferation, invasion and EMT of HCC cells
![Figure 5. Overexpressing CKAP2 heightened the proliferation, invasion and EMT of HCC cells](/cms/asset/633f86ef-2561-48d3-89e3-fc6afbd39bc2/kbie_a_1982272_f0005_oc.jpg)
Figure 6. DARS-AS1 targeted miR-3200-5p, and the latter targeted CKAP2
![Figure 6. DARS-AS1 targeted miR-3200-5p, and the latter targeted CKAP2](/cms/asset/97ceaebc-96cc-4fdf-9153-c13b64a8d974/kbie_a_1982272_f0006_oc.jpg)
Figure 7. DARS-AS1 weakened the tumor-suppressive effect mediated by miR-3200-5p overexpression
![Figure 7. DARS-AS1 weakened the tumor-suppressive effect mediated by miR-3200-5p overexpression](/cms/asset/ba5b8f2c-240f-4df7-b5a4-7c65ec04fd09/kbie_a_1982272_f0007_oc.jpg)
Availability of data and material
The data sets used and analyzed during the current study are available from the corresponding author on reasonable request.